Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I

Authors

John F. DiPersio, Washington University School of Medicine in St. LouisFollow
et alFollow

Journal

Haematologica

Publication Date

2013

Volume

98

Issue

12

Inclusive Pages

1865-1871

Document Type

Open Access Publication

DOI

10.3324/haematol.2013.092155

Rights and Permissions

John F. DiPersio, et al. (2013) Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I. Haematologica 98(12):1865-1871. Doi:10.3324/haematol.2013.092155. Obtained from the Haematologica Journal website http://www.haematologica.org

Recommended Citation

DiPersio, John F. and et al, "Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I." Haematologica. 98, 12. 1865-1871. (2013).
https://digitalcommons.wustl.edu/open_access_pubs/4367